【结 构 式】 |
【药物名称】Entecavir, BMS-200475, SQ-34676 【化学名称】(1S,3R,4S)-9-[4-Hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]guanine 【CA登记号】142217-69-4, 209216-23-9 (monohydrate) 【 分 子 式 】C12H15N5O3 【 分 子 量 】277.28505 |
【开发单位】Bristol-Myers Squibb (Originator) 【药理作用】Anti-Hepatitis B Virus Drugs, Anti-Hepatitis Virus Drugs, ANTIINFECTIVE THERAPY, Antiviral Drugs |
合成路线1
【1】 Zhang L,Zeng Z,et al.2006.Preparation of entecavir.发明专利申请公开说明书.CN 1861602 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14383 | 6-(benzyloxy)-9H-purin-2-ylamine; 6-(benzyloxy)-9H-purin-2-amine | 19916-73-5 | C12H11N5O | 详情 | 详情 |
(II) | 66320 | C25H32O5 | 详情 | 详情 | ||
(III) | 66321 | 6-(benzyloxy)-9-((1R,2R,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-(2,2-dimethyl-1,3-dioxolan-4-yl)cyclopentyl)-9H-purin-2-amine | C37H41N5O5 | 详情 | 详情 | |
(IV) | 66322 | ((1S,2S,3R,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)methyl)cyclopentyl)methanol | C33H35N5O4 | 详情 | 详情 | |
(V) | 66323 | 6-(benzyloxy)-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-9H-purin-2-amine | 204845-95-4 | C33H33N5O3 | 详情 | 详情 |
合成路线2
【1】 Zhou MX, Reiff EA, et aL 2005. Process for the preparation of entecavir and novel intennediates thereof via carbonr-silicon oxiadation. US 2005272932 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 66324 | ((5S)-5-((benzyloxy)methyl)-4-(dimethyl(phenyl)silyl)cyclopent-1-en-1-yl)methanol | C22H28O2Si | 详情 | 详情 | |
(II) | 66325 | ((2S)-2-((benzyloxy)methyl)-3-(((4-methoxybenzyl)oxy)methyl)cyclopent-3-en-1-yl)dimethyl(phenyl)silane | C30H36O3Si | 详情 | 详情 | |
(III) | 66326 | ((2S)-2-((benzyloxy)methyl)-3-(((4-methoxybenzyl)oxy)methyl)cyclopent-3-en-1-yl)dimethylsilanol | C24H32O4Si | 详情 | 详情 | |
(IV) | 66327 | ((2S)-2-((benzyloxy)methyl)-3-(((4-methoxybenzyl)oxy)methyl)cyclopent-3-en-1-yl)dimethyl((2-phenylpropan-2-yl)oxy)silane | C33H42O4Si | 详情 | 详情 | |
(V) | 66328 | ((5S)-5-((benzyloxy)methyl)-4-(dimethyl((2-phenylpropan-2-yl)oxy)silyl)cyclopent-1-en-1-yl)methanol | C25H34O3Si | 详情 | 详情 | |
(VI) | 66329 | ((1S,2R,5S)-2-((benzyloxy)methyl)-3-(dimethyl((2-phenylpropan-2-yl)oxy)silyl)-6-oxabicyclo[3.1.0]hexan-1-yl)methanol | C25H34O4Si | 详情 | 详情 | |
(VII) | 66330 | (1R,2R,5R)-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-2-((benzyloxy)methyl)-1-(hydroxymethyl)-3-(1,1,3,3-tetramethyl-3-phenyldisiloxanyl)cyclopentanol | C36H45N5O5Si2 | 详情 | 详情 | |
(VIII) | 66331 | ((2R,3R,4R)-4-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-2-((benzyloxy)methyl)-3-hydroxy-3-(hydroxymethyl)cyclopentyl)dimethylsilanol | C28H35N5O5Si | 详情 | 详情 | |
(IX) | 66332 | ((2R,3R,4R)-4-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-2-((benzyloxy)methyl)-3-hydroxy-3-(hydroxymethyl)cyclopentyl)dimethylsilanol | C26H29N5O5 | 详情 | 详情 | |
(X) | 66333 | 2-amino-9-((1R,3S,4R)-3-((benzyloxy)methyl)-4-hydroxy-2-methylenecyclopentyl)-3H-purin-6(9H)-one | C19H21N5O3 | 详情 | 详情 |
合成路线3
The regioselective reaction of cyclopentadiene (I) and sodium or commercial sodium cyclopentadienide (II) with benzyl chloromethyl ether (III) by means of the chiral catalyst (-)-diisopinocampheylborane in THF, followed by hydroxylation with H2O2/NaOH, gives (1S-trans)-2-(benzyloxymethyl)-3-cyclopenten-1-ol (IV), which is regioselectively epoxidized with tert-butyl hydroperoxide and vanadyl acetylacetonate in 2,2,4-trimethylpentane, yielding [1S-(1alpha,2alpha,3beta,5alpha)-2-(benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol (V). The protection of (V) with benzyl bromide and NaH affords the corresponding ether (VI), which is condensed with 6-O-benzylguanine (VII) by means of LiH in DMF to give the guanine derivative (VIII). The protection of the amino group of (VIII) with 4-methoxyphenyl(diphenyl)chloromethane (IX), TEA and DMAP in dichloromethane gives intermediate (X), which is oxidized at the free hydroxyl group with methylphosphonic acid, DCC and oxalic acid in DMSO or Dess Martin periodinane in dichloromethane, yielding the cyclopentanone derivative (XI). The reaction of (XI) with (i) Zn/TiCl4/CH2Br2 complex in THF/CH2Cl2, (ii) activated Zn/PbCl2/CH2I2/TiCl4 in THF/CH2Cl2 (2), (iii) Nysted reagent/TiCl4 in THF/CH2Cl2 or (iv) Tebbe reagent in toluene affords the corresponding methylene derivative (XII), which is partially deprotected with 3N HCl in hot THF, providing the dibenzylated compound (XI). Finally, this compound is treated with BCl3 in dichloromethane. (Scheme 18263401a)
【1】 Bisacchi, G.S.; Chao, S.T.; Bachard, C.; et al.; BMS-200475. A novel carbocyclic 2'-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro. Bioorg Med Chem Lett 1997, 7, 2, 127. |
【2】 Castaner, J.; Graul, A.; BMS-200475. Drugs Fut 1999, 24, 111, 1173. |
【3】 Zahler, R.; Slusarchyk, W.A. (Bristol-Myers Squibb Co.); Hydroxymethyl(methylenecyclopentyl)purines and pyrimidines. EP 0481754; JP 1992282373; US 5206244 . |
【4】 Bisacchi, G.S.; Sundeen, J.E. (Bristol-Myers Squibb Co.); Improved process for preparing the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one. WO 9809964 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11183 | 1,3-Cyclopentadiene | C5H6 | 详情 | 详情 | |
(II) | 29887 | Sodium cyclopentadienide | 4984-82-1 | C5H5Na | 详情 | 详情 |
(III) | 14560 | Benzyl chloromethyl ether; 1-[(chloromethoxy)methyl]benzene | 3587-60-8 | C8H9ClO | 详情 | 详情 |
(IV) | 29888 | (1S,2R)-2-[(benzyloxy)methyl]-3-cyclopenten-1-ol | C13H16O2 | 详情 | 详情 | |
(V) | 29889 | (1S,2R,3S,5R)-2-[(benzyloxy)methyl]-6-oxabicyclo[3.1.0]hexan-3-ol | C13H16O3 | 详情 | 详情 | |
(VI) | 29890 | (1S,2R,3S,5R)-3-(benzyloxy)-2-[(benzyloxy)methyl]-6-oxabicyclo[3.1.0]hexane; benzyl (1S,2R,3S,5R)-2-[(benzyloxy)methyl]-6-oxabicyclo[3.1.0]hex-3-yl ether | C20H22O3 | 详情 | 详情 | |
(VII) | 14383 | 6-(benzyloxy)-9H-purin-2-ylamine; 6-(benzyloxy)-9H-purin-2-amine | 19916-73-5 | C12H11N5O | 详情 | 详情 |
(VIII) | 29891 | (1S,2S,3S,5S)-5-[2-amino-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-[(benzyloxy)methyl]cyclopentanol | C32H33N5O4 | 详情 | 详情 | |
(IX) | 12700 | 4-[Chloro(diphenyl)methyl]phenyl methyl ether; 1-[Chloro(diphenyl)methyl]-4-methoxybenzene; p-Anisylchlorodiphenylmethane | 14470-28-1 | C20H17ClO | 详情 | 详情 |
(X) | 29892 | (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-[[(4-methoxyphenyl)(diphenyl)methyl]amino]-9H-purin-9-yl)-2-[(benzyloxy)methyl]cyclopentanol | C52H49N5O5 | 详情 | 详情 | |
(XI) | 29893 | (2R,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-[[(4-methoxyphenyl)(diphenyl)methyl]amino]-9H-purin-9-yl)-2-[(benzyloxy)methyl]cyclopentanone | C52H47N5O5 | 详情 | 详情 | |
(XII) | 29894 | 6-(benzyloxy)-9-[(1S,3R,4S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylenecyclopentyl]-N-[(4-methoxyphenyl)(diphenyl)methyl]-9H-purin-2-amine; N-(6-(benzyloxy)-9-[(1S,3R,4S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylenecyclopentyl]-9H-purin-2-yl)-N-[(4-methoxyphenyl)(diphenyl)methyl]amine | 142217-80-9 | C53H49N5O4 | 详情 | 详情 |
(XIII) | 29895 | 2-amino-9-[(1S,3R,4S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylenecyclopentyl]-1,9-dihydro-6H-purin-6-one | 142217-81-0 | C26H27N5O3 | 详情 | 详情 |